{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Respiratory+Therapy&page=53", "query": { "condition": "Respiratory Therapy", "page": 53 }, "page_size": 10 }, "pagination": { "page": 53, "page_size": 10, "total_count": 4666, "total_pages": 467, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Respiratory+Therapy&page=54&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Respiratory+Therapy&page=52&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T02:26:18.467Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01450761", "title": "Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Small Cell Lung Carcinoma" ], "interventions": [ { "name": "Ipilimumab", "type": "BIOLOGICAL" }, { "name": "Placebo matching Ipilimumab", "type": "BIOLOGICAL" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1351, "start_date": "2011-12-13", "completion_date": "2017-05-17", "has_results": true, "last_update_posted_date": "2020-07-08", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 42, "location_summary": "Hot Springs, Arkansas • Auburn, California • La Jolla, California + 34 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Auburn", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Fort Myers", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01450761" }, { "nct_id": "NCT02094261", "title": "Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non Small Cell Lung Cancer" ], "interventions": [ { "name": "AZD9291", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 210, "start_date": "2014-05-20", "completion_date": "2023-11-07", "has_results": true, "last_update_posted_date": "2024-11-06", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 9, "location_summary": "La Jolla, California • Orange, California • New Haven, Connecticut + 6 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Norwalk", "state": "Connecticut" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02094261" }, { "nct_id": "NCT01134042", "title": "Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Furoate/Vilanterol Inhalation Powder", "type": "DRUG" }, { "name": "Fluticasone Furoate Inhalation Powder", "type": "DRUG" }, { "name": "Fluticasone Propionate Inhalation Powder", "type": "DRUG" }, { "name": "Placebo Inhalation Powder 1", "type": "OTHER" }, { "name": "Placebo Inhalation Powder 2", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 587, "start_date": "2010-06", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2017-01-11", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 23, "location_summary": "Bell Gardens, California • Huntington Beach, California • Long Beach, California + 19 more", "locations": [ { "city": "Bell Gardens", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01134042" }, { "nct_id": "NCT06272994", "title": "Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Community-acquired Pneumonia" ], "interventions": [ { "name": "MRSA Nasal Swab PCR", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 277, "start_date": "2024-04-03", "completion_date": "2025-02-27", "has_results": true, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06272994" }, { "nct_id": "NCT06896162", "title": "PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Solid Tumor Malignancies", "Metastatic Cancer", "Breast Cancer", "Colorectal Cancer", "Lung Cancer", "Bladder Cancer" ], "interventions": [ { "name": "Expert Review", "type": "OTHER" }, { "name": "Blood or tissue samples collection.", "type": "OTHER" }, { "name": "The Precision Oncology Navigation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2025-06-27", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06896162" }, { "nct_id": "NCT04483973", "title": "SPI-1005 Treatment in Severe COVID-19 Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19", "Coronavirus", "Coronavirus Infection", "Corona Virus Infection" ], "interventions": [ { "name": "Ebselen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sound Pharmaceuticals, Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2021-08-27", "completion_date": "2023-06-06", "has_results": true, "last_update_posted_date": "2026-06-29", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 7, "location_summary": "New Haven, Connecticut • Boise, Idaho • Kansas City, Kansas + 4 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Boise", "state": "Idaho" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04483973" }, { "nct_id": "NCT03746483", "title": "OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Exocrine Pancreatic Insufficiency (EPI)", "Cystic Fibrosis (CF)" ], "interventions": [ { "name": "MS1819", "type": "DRUG" }, { "name": "Porcine PERT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Entero Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 41, "start_date": "2019-01-10", "completion_date": "2019-07-27", "has_results": true, "last_update_posted_date": "2022-06-06", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 11, "location_summary": "Long Beach, California • Altamonte Springs, Florida • Miami, Florida + 8 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Altamonte Springs", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Glenview", "state": "Illinois" }, { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03746483" }, { "nct_id": "NCT06941441", "title": "PAH Exercise Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Arterial Hypertension (PAH)", "Exercise Therapy" ], "interventions": [ { "name": "Home exercise program", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2025-04-15", "completion_date": "2026-09-30", "has_results": false, "last_update_posted_date": "2025-04-23", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06941441" }, { "nct_id": "NCT01134705", "title": "Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rhinitis, Allergic, Perennial" ], "interventions": [ { "name": "Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol", "type": "DRUG" }, { "name": "Placebo Nasal Aerosol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 474, "start_date": "2010-05", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2012-05-23", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 35, "location_summary": "Los Angeles, California • Mission Viejo, California • San Diego, California + 30 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01134705" }, { "nct_id": "NCT05104749", "title": "Homeopathic Treatment of Post-acute COVID-19 Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Post-acute Covid-19 Syndrome" ], "interventions": [ { "name": "Homeopathic Medication", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Southwest College of Naturopathic Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 77, "start_date": "2021-09-15", "completion_date": "2022-04-22", "has_results": true, "last_update_posted_date": "2023-11-22", "last_synced_at": "2026-10-30T02:26:18.467Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05104749" } ] }